Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa

Shandir Ramlagan, Violeta J Rodriguez, Karl Peltzer, Robert A C Ruiter, Deborah L Jones, Sibusiso Sifunda, Shandir Ramlagan, Violeta J Rodriguez, Karl Peltzer, Robert A C Ruiter, Deborah L Jones, Sibusiso Sifunda

Abstract

We evaluate the impact of a multi-session cognitive behavioral prevention of mother to child transmission (PMTCT) intervention on antiretroviral therapy (ART) adherence. A total of 683 women were enrolled into a randomized control trial conducted at twelve community health centres (CHCs) in Mpumalanga Province. Participants were randomized to Standard Care or Enhanced PMTCT Intervention (EI). EI received three group and three individual intervention sessions. EI impact was ascertained on ART adherence (baseline vs 12 months post-partum). Women in the intervention groups were less likely to remain stable with regards to ART adherence over time compared to the control groups. In predicting if women become adherent over time, the intervention condition had no impact. However, the intervention condition was significantly positively associated with change to non-adherence. The enhanced cognitive-behavioral PMTCT intervention did not show any improvement in relation to maternal ART adherence relative to standard PMTCT care.Trial registration Clinicaltrials.gov: number NCT02085356.

Keywords: ART adherence; Maternal; Pregnancy; Randomized Control Trial; South Africa.

Conflict of interest statement

The authors declare that they have no competing interests. The funding sponsors had no role in the design of the study; in the collection, analyses, nor interpretation of data; in the writing of the manuscript; nor the decision to publish the results.

Figures

Fig. 1
Fig. 1
“Protect Your Family” RCT design

References

    1. UNAIDS . Terminology guidelines. Geneva: UNAID; 2015.
    1. South African National Aids Council (SANAC) Let our actions count: reflections on NSP 2012–2016 and moving forward to NSP 2017–2022. Pretoria: SANAC; 2016.
    1. AIDSinfo. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. . Accessed 4 May 2018.
    1. Kreitchmann R, Harris DR, Kakehas F, et al. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDs. 2012;26(8):486–495. doi: 10.1089/apc.2012.0013.
    1. Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study. AIDS Patient Care STDs. 2013;27(4):208–210. doi: 10.1089/apc.2013.0005.
    1. Chesney MA, Icknics J, Hecht FM, et al. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(supply A):5271–5278.
    1. Hecht FM, Colfax G, Swanson M, Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. In: Fifth Conference on retroviruses and opportunistic infections. Chicago, 1998.
    1. Kastrissios H, Suarez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke TF. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial. AIDS. 1998;12:2295–2303. doi: 10.1097/00002030-199817000-00011.
    1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi: 10.7326/0003-4819-133-1-200007040-00004.
    1. Wahl LM, Nowak MA. Adherence and drug resistance: predictions for therapy outcome. Proc R Soc B. 2000;267:835–843. doi: 10.1098/rspb.2000.1079.
    1. Adeniy OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert J. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18:175. doi: 10.1186/s12879-018-3087-8.
    1. Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26:2039–2052. doi: 10.1097/QAD.0b013e328359590f.
    1. Horne R, Buick D, Fishe M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004;15:38–44. doi: 10.1258/095646204322637245.
    1. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64(1):41–46. doi: 10.1016/j.jpsychores.2007.05.004.
    1. UNAIDS . Ending AIDS: progress towards 90–90–90 targets. Geneva: UNAID; 2017.
    1. Avert. HIV and AIDS in South Africa. . Accessed 4 May 2018.
    1. Peltzer K, Weiss SM, Soni M, et al. A cluster randomized controlled trial of lay health worker support for prevention of mother to child transmission of HIV (PMTCT) in South Africa. AIDS Res Ther. 2017;14:61. doi: 10.1186/s12981-017-0187-2.
    1. Futterman D, Shea J, Besser M, et al. Mamekhaya: a pilot study combining a cognitivebehavioral intervention and mentor mothers with PMTCT services in South Africa. AIDS Care. 2010;22(9):1093–1100. doi: 10.1080/09540121003600352.
    1. Ngidi WH, Naidoo JR, Ncama BP, Luvuno ZPB, Mashamba- Thompson TP. Mapping evidence of interventions and strategies to bridge the gap in the implementation of the prevention of mother-to-child transmission of HIV programme policy in sub-Saharan countries: a scoping review. Afr J Prm Health Care Fam Med. 2017;9(1):a1368.
    1. Geldsetzer P, Yapa HM, Vaikath M, et al. A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care. J Int AIDS Soc. 2016;19(1):20679. doi: 10.7448/IAS.19.1.20679.
    1. Jones D, Peltzer K, Weiss SM, et al. Implementing comprehensive prevention of mother-to-child transmission and HIV prevention for South African couples: study protocol for a randomized controlled trial. Trials. 2014;15:417. doi: 10.1186/1745-6215-15-417.
    1. United Nations Children’s Fund (UNICEF). Options B and B+: Key considerations for countries to implement an equity focused approach. Eliminating new HIV infections among children and keeping mothers living with HIV alive and well. . Accessed 30 Feb 2018.
    1. World Health Organization (WHO). Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. . Accessed 20 Mar 2018.
    1. Ramlagan S, Peltze K, Ruiter RAC, Barylski NA, Weiss SM, Sifunda S. Prevalence and factors associated with fixed-dose combination antiretroviral drugs adherence among HIV-positive pregnant women on option B treatment in Mpumalanga Province, South Africa. Int J Environ Res Public Health. 2018;15(1):161. doi: 10.3390/ijerph15010161.
    1. Department of Health (DoH). South African Antiretroviral Treatment Guidelines 2013. . Accessed 5 Mar 2018.
    1. NIMH Multisite HIV/STD Prevention Trial for African American Couples Group Designing an audio computer-assisted self-interview system in a multisite trial: a brief report. J Acquir Immune Defic Syndr. 2008;49:S52–S58. doi: 10.1097/QAI.0b013e318184481a.
    1. DoH. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults, 2014. . Accessed 5 Mar 2018.
    1. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care. 2000;12:255–266. doi: 10.1080/09540120050042891.
    1. Straus MA. Measuring intrafamily conflict and violence: the Conflict Tactics (CT) Scales. J Marriage Fam. 1979;41:75–86. doi: 10.2307/351733.
    1. Straus MA, Gelles RJ. Violence in the American family. J Soc Issues. 1979;35:15–39. doi: 10.1111/j.1540-4560.1979.tb00799.x.
    1. Kalichman SC, Simbayi LC, Jooste S, et al. Development of a brief scale to measure AIDS-related stigma in South Africa. AIDS Behav. 2005;9:135–143. doi: 10.1007/s10461-005-3895-x.
    1. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–786. doi: 10.1192/bjp.150.6.782.
    1. Lawrie TA, Hofmey GJ, de Jager M, Berk M. Validation of the Edinburgh postnatal depression scale on a cohort of South African women. S Afr Med J. 1998;88:1340–1344.
    1. Allen J, Le H. An additional measure of overall effect size for logistic regression models. J Educ Behav Stat. 2008;33(4):416–441. doi: 10.3102/1076998607306081.
    1. Asparouhov T, Muthén B. Multiple imputation with Mplus. . Accessed 5 Mar 2018.
    1. Muthén L, Muthén B. Mplus (Version 7.4). Los Angeles: MPlus; 2014.
    1. DoH. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria: National Department of Health; 2015.
    1. Peltzer K, Abbamonte JM, Mandell LN, et al. The effect of male involvement and a prevention of mother to child transmission (PMTCT) intervention on depressive symptoms in perinatal HIV-infected rural South African women. Arch Womens Ment Health. 2019;1:1–11.
    1. Peltzer K, Babayigit S, Rodriguez VJ, et al. Effect of a multicomponent behavioural PMTCT cluster randomized controlled trial on HIV stigma reduction among perinatal HIV positive women in Mpumalanga province, South Africa. Sahara J. 2018;15(1):80–88. doi: 10.1080/17290376.2018.1510787.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir